Clinical Trial Update: Phase I Study of the Combination of Anlotinib With Gefitinib [NA]

View source ↗

Summary

This document provides an update on a Phase I trial evaluating the combination of Anlotinib and Gefitinib in non-squamous non-small cell lung cancer. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Gefitinib (Gefitinib)

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Non-squamous Non-small Cell Lung Cancer | NA | Status: UNKNOWN